BNP Paribas Arbitrage SA Reduces Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

BNP Paribas Arbitrage SA lessened its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 18.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 147,697 shares of the real estate investment trust’s stock after selling 33,844 shares during the quarter. BNP Paribas Arbitrage SA owned approximately 0.07% of Omega Healthcare Investors worth $4,713,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in OHI. Ffcm LLC boosted its stake in shares of Omega Healthcare Investors by 197.6% during the 2nd quarter. Ffcm LLC now owns 3,402 shares of the real estate investment trust’s stock worth $115,000 after acquiring an additional 2,259 shares during the period. Bronfman E.L. Rothschild L.P. boosted its stake in shares of Omega Healthcare Investors by 167.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,432 shares of the real estate investment trust’s stock worth $113,000 after acquiring an additional 2,150 shares during the period. Chicago Partners Investment Group LLC boosted its stake in shares of Omega Healthcare Investors by 656.6% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 6,015 shares of the real estate investment trust’s stock worth $193,000 after acquiring an additional 5,220 shares during the period. ARP Americas LLC bought a new position in shares of Omega Healthcare Investors during the 2nd quarter worth approximately $218,000. Finally, Good Life Advisors LLC bought a new position in shares of Omega Healthcare Investors during the 3rd quarter worth approximately $209,000. 68.14% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director Craig R. Callen purchased 10,000 shares of Omega Healthcare Investors stock in a transaction on Thursday, November 2nd. The shares were purchased at an average price of $27.38 per share, for a total transaction of $273,800.00. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Bernard J. Korman purchased 100,000 shares of Omega Healthcare Investors stock in a transaction on Tuesday, October 31st. The stock was bought at an average price of $28.24 per share, for a total transaction of $2,824,000.00. Following the transaction, the director now directly owns 903,895 shares in the company, valued at approximately $25,525,994.80. The disclosure for this purchase can be found here. Insiders own 1.54% of the company’s stock.

Shares of Omega Healthcare Investors, Inc. (OHI) traded down $0.41 during mid-day trading on Monday, reaching $26.78. The company had a trading volume of 2,520,889 shares, compared to its average volume of 2,175,437. The company has a market cap of $5,280.00, a price-to-earnings ratio of 8.00, a P/E/G ratio of 2.82 and a beta of 0.49. Omega Healthcare Investors, Inc. has a twelve month low of $26.43 and a twelve month high of $35.14. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.40 and a quick ratio of 3.40.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Tuesday, October 31st were given a dividend of $0.65 per share. The ex-dividend date was Monday, October 30th. This represents a $2.60 dividend on an annualized basis and a yield of 9.71%. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.64. Omega Healthcare Investors’s payout ratio is currently 333.33%.

Several analysts recently weighed in on the company. Zacks Investment Research cut Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Friday, November 3rd. SunTrust Banks reissued a “hold” rating and set a $30.00 price target on shares of Omega Healthcare Investors in a report on Wednesday, November 1st. Hilliard Lyons cut Omega Healthcare Investors to a “buy” rating in a report on Wednesday, November 1st. TheStreet cut Omega Healthcare Investors from a “b-” rating to a “c” rating in a report on Monday, October 30th. Finally, Stifel Nicolaus cut Omega Healthcare Investors from a “buy” rating to a “hold” rating and dropped their price objective for the company from $35.00 to $29.00 in a report on Tuesday, October 31st. One analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $31.83.

WARNING: “BNP Paribas Arbitrage SA Reduces Position in Omega Healthcare Investors, Inc. (NYSE:OHI)” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2017/12/04/bnp-paribas-arbitrage-sa-sells-33844-shares-of-omega-healthcare-investors-inc-ohi.html.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply